Gene · 2189
FANCG: FA complementation group G
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FANCG: FA complementation group G. Genes, record 2189. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2189
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15287 | Fanconi anemia group G protein | 622 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents31
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025038035 A | 2025-03-18 | 4366 | O15287 | Espacenet |
| US 12134655 B2 | 2024-11-05 | 4366 | O15287 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 6174 | O15287 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 151 | O15287 | Espacenet |
| EP 4268831 A2 | 2023-11-01 | 126 | O15287 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 30669 | O15287 | Espacenet |
| JP 2022530667 A | 2022-06-30 | 4366 | O15287 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 133640 | O15287 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3888 | O15287 | Espacenet |
| EP 3849565 A1 | 2021-07-21 | 126 | O15287 | Espacenet |
1 to 10 of 31
See all 31 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants852
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FANCG papers | Newest fiscal year |
|---|---|---|---|
| R01HL052725 | Molecular Pathogenesis of Fanconi Anemia | 25 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| ZIACP010144 | Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes | 12 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| ZIAAG000688 | Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins | 10 | 2025 |
| ZIAHG000029 | Fanconi Anemia: Genotype-Phenotype Correlations | 10 | 2025 |
| ZIAAG000746 | Repair of localized DNA damage | 8 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 7 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 7 | 2025 |
| ZICHG200346 | NHGRI/DIR Genomics Core | 7 | 2025 |
1 to 10 of 852Source NIH's project files
See all 852 nih grantsPapers1,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical, cytogenetic, and molecular insights from 32 years of the Portuguese Fanconi anemia cohort. | Genet Med Open | 2026 | 42824411 | PubTator, text mining | PubMed |
| ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism. | Sci Adv | 2026 | 42536749 | PubTator, text mining | PubMed |
| Site-Specific Genomic Markers Associated with Outcomes of PD-1 Blockade in Gastric and Esophagogastric Junction Cancer: Analysis of Japan's C-CAT Registry. | BioDrugs | 2026 | 42045774 | PubTator, text mining | PubMed |
| Integrative Analysis of Telomere-Related Genes Reveals Prognostic Signatures in Laryngeal Cancer. | Int J Genomics | 2026 | 41959623 | PubTator, text mining | PubMed |
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group. | Asian Pac J Cancer Prev | 2026 | 41660923 | PubTator, text mining | PubMed |
| Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. | Ann Surg Oncol | 2026 | 41085800 | PubTator, text mining | PubMed |
| Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. | Nat Commun | 2025 | 41038821 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
1 to 10 of 1,427
See all 1,427 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2189
GET https://conductscience.org/api/genes/v1/2189/patents?page=2